LPP-AS2: A Key Regulator of Cell Signaling Pathways (G339929)

Target Name: LPP-AS2

NCBI ID: G339929

LPP-AS2

Other Name(s): MYCLo-6 | LPP antisense RNA 2 | MYCLo-5

LPP-AS2: A Key Regulator of Cell Signaling Pathways

LPP-AS2 (long-chain polyprotein-AS2) is a protein that is expressed in various tissues and cells in the body. It is a key regulator of cell signaling pathways and has been implicated in a number of diseases, including cancer.

One of the key functions of LPP-AS2 is its role as a negative regulator of the TGF-β signaling pathway. TGF-β is a cytokine that plays a critical role in cell signaling and has been implicated in a number of diseases, including cancer. It is a transcription factor that regulates gene expression and is involved in the development and maintenance of tissues and organs. TGF-β signaling is also involved in the regulation of cell division, cell survival, and the regulation of cell signaling pathways.

LPP-AS2 is a negative regulator of TGF-β signaling, which means that it works to inhibit the activity of TGF-β and to prevent it from regulating gene expression. This is important because TGF-β is often involved in the development and progression of many diseases, including cancer. By inhibiting TGF-β signaling, LPP-AS2 may be able to reduce the risk of these diseases.

In addition to its role as a negative regulator of TGF-β signaling, LPP-AS2 is also involved in the regulation of cell signaling pathways. It is a regulator of the PI3K/Akt signaling pathway, which is involved in the regulation of cell survival and the maintenance of tissues and organs. LPP-AS2 is also involved in the regulation of the NF-kappa-B signaling pathway, which is involved in the regulation of inflammation and immune responses.

The role of LPP-AS2 in cell signaling pathways is important because it is involved in the regulation of many different processes in the body. It is involved in the regulation of cell growth, cell differentiation, and cell survival, as well as the regulation of cell signaling pathways that are involved in the development and maintenance of tissues and organs. LPP-AS2 may also be involved in the regulation of inflammation and immune responses, which are important for maintaining the health and function of the body.

As a drug target or biomarker, LPP-AS2 is of interest because it is involved in the regulation of many different processes in the body and it is involved in the development and progression of many diseases. It is also a negative regulator of TGF-β signaling, which means that it may be able to reduce the risk of these diseases. Further research is needed to fully understand the role of LPP-AS2 in cell signaling pathways and its potential as a drug target or biomarker.

Protein Name: LPP Antisense RNA 2

The "LPP-AS2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LPP-AS2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets